Briefing
Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease
Among patients who were NGS-positive for residual disease before transplant, 3-year cumulative incidence of relapse was 19% with myeloablative conditioning (MAC) vs 67% with reduced-intensity conditioning (RIC) (P<.001); 3-year OS 61% vs 43% (P=0.02). In multivariable analysis of NGS-positive patients, RIC was associated with increased relapse (HR 6.38, 95% CI 3.37-12.10, P<.001), decreased RFS (HR 2.94, P<.001), and decreased OS (HR 1.97, 95% CI 1.17-3.30, P=0.01). Level 2 (MRD analysis of a randomized conditioning-intensity trial).
- Design: paper
- Assay: NGS genomic evidence of residual disease in blood before alloHCT (BMT CTN 0901)